Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BSD Medical (Long Term Investment Oriented) -- Ignore unavailable to you. Want to Upgrade?

To: geoffrey Wren who wrote (59)	12/19/2012 4:28:39 PM
From: pleonastic	Respond to of 178

>I'd be more impressed if they would quantify things to make it easy to compare periods. If this thing is ramping up, I would like to know exactly what they sold this quarter and what increase that is over the immediate prior quarter. < That’s certainly a legitimate complaint, and I too have been harping about it. But, they have been providing updates – jut not ones that simply relate to their SEC filings. While I grouse about the lack of simple information, I can also sympathize with their situation. Their FPU plan is an innovative approach, and it evidently is being very successful. They gave it a trial in the Salt Lake City area, where they are located. And, now, they are touting the results from the plan in some major metro areas across the country. It appears this expansion is still underway -- only some major areas are now covered, as of last information given. That said, these are large metro areas; like the Chicago area, for example. >It is too much like an advertised real estate listing where they tell you two out of three things: size, price, and location. You really have no way of knowing whether it might suit you other than to call up.< Right. But, I expect that to change, now that the company has a new CFO. The outgoing CFO was also in charge of investor relations! >BSDM issues reports that compare sales to year-ago quarters, and do not break down the sales mix. How many units sold, how many fee per uses were there, how many antennaes were sold? If they can say something is up 586%, they would be able to break it down in their press releases, and compare to the immediate prior quarter.< That is likely much harder to do than you suggest – since the actual start of the FPU plan was only about their mid-FY. Longer term, I’m confident that erratic reporting will change – this should happen SOON. But, they were surely making extra effort in those rather out-of-sync communications to provide investors with updates as soon as they could – and they are due thanks for that. Note that the very impressive immediate response to the FPU plan has so far been reported, as far as I can tell, mainly in the form of sales (items sold, not revenue booked as payments or as accounts receivable). They appear to have not yet formally accounted for the sales they suggest by comments in the 7 Aug Webinar and a later news release. The basic reasons for the much less than perfect reporting is, I believe, the newness of the FPU plan implementation and an immediate response large enough to cause some glitches. It’s even possible the regional reps have initially been overwhelmed – and, surely, the CFO would at least need formal reports from them in order to recognize the revenue, which I think would only be in the form of accounts receivable. And, actual money received can be expected to come quite a while later than sales: standard for medical markets. >Perhaps with the new CFO and perhaps with more attention to PR they will be able to issue more concrete and informative reports.< Yes, I am confident we are just seeing “growing pains” – particularly painful since the growth rate they are stating is phenomenal (and they are legally liable for the accuracy of what they say). I believe the stock market is utterly confused by the situation – so, good time to buy, right? Here are some further comments from me about the situation; and there is an interesting link in the post I responded to, about complications and delayed payments for medical marketing: http://www.investorvillage.com/smbd.asp?mb=222&mn=3805&pt=msg&mid=12394234